Announced at Pfizer Coronavirus disease vaccine The effect can be Down to 84% Six months after the second injection, Modern (Ribonucleic acid) Said that within six months after the second dose of vaccination, the effectiveness of its COVID-19 vaccine against COVID-19 was 93%.
But these two efficacy studies were conducted before the emergence of new drugs. Delta variantThis has increased experts’ concerns about the ability of the COVID vaccine to fight the virus.
Moderna said on Thursday that due to the highly contagious Delta variant, the number of breakthrough cases of the virus may increase when fully vaccinated people move indoors at the end of summer.
“We are very happy that our COVID-19 vaccine has shown a 93% lasting efficacy in six months, but recognizes that the Delta variant is a major new threat, so we must remain vigilant,” said CEO Stephane Bancel. Said in a press release.
Moderna officials warned that breakthrough cases may emerge during their work. Second quarter earnings report, Also released on Thursday.
The company said that although the effectiveness of the two doses of the vaccine is still “strong” within six months after the second injection, the immunity will weaken and ultimately affect the efficacy.
Moderna said: “Given this intersection, we believe that 3 doses of boosters may be needed before winter.”
The drug maker’s warning came as Delta accounted for 93% of all COVID-19 cases, according to Centers for Disease Control and PreventionThe global “variation of concern” considered by the CDC and the World Health Organization has been discovered in more than 100 countries and all 50 states in the United States.
The CDC stated that the Delta variant originally found in India is more likely to spread than the common cold, 1918 Spanish flu, smallpox, Ebola, Middle East respiratory syndrome and SARS, according to reports NBC Finance Channel.
So far More than 165 million Americans Fully vaccinated against COVID-19, accounting for 49.8% of the U.S. population.
According to the Wall Street Journal, more than 64 million people were vaccinated with Moderna vaccine, 88 million people were vaccinated with Pfizer, and 13 million people were vaccinated with Johnson & Johnson’s COVID vaccine. According to reports, more than 90 million eligible people in the country have not yet received a dose of COVID vaccine. CNN.
The CDC does not recommend that Americans get the third dose of the COVID vaccine.
Moderna announced that it sold $4.2 billion of COVID vaccine and 199 million doses of vaccine between April and June. The company also reported that revenue for the second quarter of 2020 was $67 million.
As of 11:47 AM Eastern Time on Thursday, Moderna’s stock price was $413.88, down $5.17 or 1.23%.
Photo: AFP/Joel Sagit
